Ann Dermatol.  2015 Aug;27(4):460-462. 10.5021/ad.2015.27.4.460.

A Case of Gonadotropin-Releasing Hormone Agonist-Induced Sterile Abscess Showing a Good Response to Systemic Steroid Therapy

Affiliations
  • 1Department of Dermatology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea. skin4u@korea.ac.kr

Abstract

No abstract available.


MeSH Terms

Abscess*
Gonadotropin-Releasing Hormone*
Gonadotropin-Releasing Hormone

Figure

  • Fig. 1 Painful tender erythematous subcutaneous swelling on abdomen. (A) Before treatment. (B) After 4 weeks of systemic steroid therapy.

  • Fig. 2 Histologic slide stained with hematoxylin and eosin reveals neutrophilic and eosinophilic infiltrates in the reticular dermis.


Reference

1. Limonta P, Manea M. Gonadotropin-releasing hormone receptors as molecular therapeutic targets in prostate cancer: Current options and emerging strategies. Cancer Treat Rev. 2013; 39:647–663.
Article
2. Choi S, Lee AK. Efficacy and safety of gonadotropin-releasing hormone agonists used in the treatment of prostate cancer. Drug Healthc Patient Saf. 2011; 3:107–119.
Article
3. Gnanaraj J, Saif MW. Hypersensitivity vasculitis associated with leuprolide (Lupron). Cutan Ocul Toxicol. 2010; 29:224–227.
Article
4. Neely EK, Hintz RL, Parker B, Bachrach LK, Cohen P, Olney R, et al. Two-year results of treatment with depot leuprolide acetate for central precocious puberty. J Pediatr. 1992; 121:634–640.
Article
5. Kim JM, Shin YL. Sterile abscess formation associated with two different forms of gonadotropin-releasing hormone agonist in central precocious puberty. Ann Pediatr Endocrinol Metab. 2012; 17:184–188.
Article
Full Text Links
  • AD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr